{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:38:30Z","timestamp":1787009910965,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/cad.0b013e328365288e","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T13:42:39Z","timestamp":1378302159000},"page":"989-998","source":"Crossref","is-referenced-by-count":29,"title":["Promestriene, a specific topic estrogen. Review of 40 years of vaginal atrophy treatment"],"prefix":"10.1097","volume":"24","author":[{"given":"Lino","family":"Del Pup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Di Francia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"De Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1155\/2008\/269571","article-title":"Dyspareunia in postmenopausal women: a critical review.","volume":"13","author":"Kao","year":"2008","journal-title":"Pain Res Manag"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/13697130802585576","article-title":"Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.","volume":"12","author":"Al-Baghdadi","year":"2009","journal-title":"Climacteric"},{"key":"R3-1-20210203","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women.","volume":"18","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2006.10.036","article-title":"Womens perspective of sexuality around the menopause: outcomes of a European telephone survey.","volume":"137","author":"Nappi","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R5-1-20210203","first-page":"533","article-title":"Rational use of vaginal promestriene.","volume":"9","author":"De Aloysio","year":"1995","journal-title":"Ital J Obstet Gynecol"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3109\/09513591003767948","article-title":"Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy.","volume":"26","author":"Santos","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"R9-1-20210203","first-page":"1","article-title":"Tropicita vaginale e colpotrophine.","volume":"1","author":"Vors","year":"1975","journal-title":"Gen Med"},{"key":"R10-1-20210203","first-page":"189","article-title":"Climateric syndrome: clinical experiences with promestriene.","volume":"97","author":"Campana","year":"1976","journal-title":"Ann Obstet Gynecol Perinat Med"},{"key":"R11-1-20210203","first-page":"125","article-title":"Study of estrogenic effects of promestriene.","volume":"25","author":"Gaudefroy","year":"1977","journal-title":"Arch Anat Cytol Pathol"},{"key":"R13-1-20210203","first-page":"627","article-title":"Prolonged treatment of atrophic vaginitis by promestriene. Results and tolerance.","volume":"31","author":"Romanini","year":"1980","journal-title":"Gynecology"},{"key":"R14-1-20210203","first-page":"551","article-title":"Promestriene interest in the treatment of postmenopausal atrophic vaginitis.","volume":"32","author":"Wurch","year":"1981","journal-title":"Gynecology"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0378-5122(82)90054-8","article-title":"Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa.","volume":"4","author":"Wolff","year":"1982","journal-title":"Maturitas"},{"key":"R16-1-20210203","first-page":"189","article-title":"Sexual dysfunction secondary to gynecological cancer. Their local treatment diether estradiol without systemic hormonal activities.","volume":"78","author":"Wolff","year":"1983","journal-title":"French Gynecol Obst Rev"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0039-128X(83)90012-0","article-title":"The percutaneous absorption and excretion of promestriene 3-propoxy-17beta-methoxy-1,3,510-estratriene in rats and humans.","volume":"41","author":"Moore","year":"1983","journal-title":"Steroids"},{"key":"R19-1-20210203","first-page":"727","article-title":"Promestriene interest in the treatment of voiding dysfunction in postmenopausal.","volume":"81","author":"Arvis","year":"1986","journal-title":"French Gynecol Obst Rev"},{"key":"R20-1-20210203","first-page":"1562","article-title":"Local and systemic estrogenic activity of the topics used to treat vaginal atrophy.","volume":"44","author":"Romanini","year":"1986","journal-title":"Med Hyg"},{"key":"R21-1-20210203","first-page":"611","article-title":"Sonographic changes in the immature uterus under the influence of estrogen treatment.","volume":"34","author":"Colle","year":"1987","journal-title":"Ann Pediatr (Paris)"},{"key":"R23-1-20210203","first-page":"101","article-title":"Getting evidence of the lack of systemic effect promestriene used at high doses.","volume":"39","author":"Wurch","year":"1988","journal-title":"Gynecocology"},{"key":"R24-1-20210203","first-page":"313","article-title":"Comparison between the effects of two estrogens administered by the vaginal route on the vagina of postmenopausal women.","volume":"15","author":"Wurch","year":"1988","journal-title":"Contracept Fertil Sex"},{"key":"R27-1-20210203","first-page":"467","article-title":"Biological activity of promestriene on the genital tract of ovariectomized rat.","volume":"42","author":"Borrelli","year":"1990","journal-title":"Minerva Gynecol"},{"key":"R29-1-20210203","first-page":"559","article-title":"Effects of topical promestriene on glucose and lipid metabolism in diabetic patients with post menopausal vaginal atrophy.","volume":"17","author":"Lepore","year":"1990","journal-title":"Contracept Fertil Sex"},{"key":"R30-1-20210203","first-page":"257","article-title":"Vaginal delivery of promestriene and post menopausal stress incontinence.","volume":"17","author":"Carbonaro","year":"1990","journal-title":"Contracept Fertil Sex"},{"key":"R32-1-20210203","first-page":"325","article-title":"Promestriene use in the treatment of multiple vaginal delivery lesions.","volume":"18","author":"Mignano","year":"1991","journal-title":"Contracept Fertil Sex"},{"key":"R34-1-20210203","first-page":"1","article-title":"Therapeutic strategies in recurrent vaginitis: efficacy of promestriene.","volume":"1","author":"De Punzio","year":"1992","journal-title":"Int J Gynecol Obstet"},{"key":"R35-1-20210203","first-page":"160","article-title":"Use of promestriene in the prevention of side effects during treatment with GnRH analogues.","volume":"4","author":"Perino","year":"1992","journal-title":"Int J Gynecol Obstet"},{"key":"R37-1-20210203","first-page":"45","article-title":"Lack of influence of promestriene vaginally administered on circulating levels of hormones and estrogen dependent hepatic proteins in postmenopausal women.","volume":"43","author":"Bonneton","year":"1992","journal-title":"Gynecocology"},{"key":"R40-1-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/09513590701521750","article-title":"Presurgical promestriene therapy in postmenopausal women with stress urinary incontinence.","volume":"23","author":"Tinelli","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"R41-1-20210203","first-page":"245","article-title":"Topical promestriene in the vulvo, cervical and vaginal menopausal atrophy treatment.","volume":"20","author":"Grossi","year":"1993","journal-title":"Contracept Fertil Sex"},{"key":"R42-1-20210203","first-page":"25","article-title":"Clinical and urodinamic effects of promestriene on stress urinary incontinence in menopause.","volume":"7","author":"Minini","year":"1993","journal-title":"Urogynecol Int J"},{"key":"R43-1-20210203","first-page":"109","article-title":"Use of promestriene in the treatment of urogynecologic disorders in postmenopausal women.","volume":"8","author":"Cervigni","year":"1994","journal-title":"Urogynecol Int J"},{"key":"R49-1-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2012.01.017","article-title":"Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: a pilot study.","volume":"72","author":"Del Pup","year":"2012","journal-title":"Maturitas"},{"key":"R50-1-20210203","first-page":"68","article-title":"Vaginal estrogen therapy for oncological patients: practical advice to improve investigations adequacy and quality of life.","volume":"4","author":"Del Pup","year":"2010","journal-title":"Gynecol Endocrinol Bull"},{"key":"R51-1-20210203","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/09513590.2011.652717","article-title":"Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.","volume":"28","author":"Del Pup","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R52-1-20210203","first-page":"593","article-title":"Safety of promestriene capsule used in postmenopausal atrophic vaginitis.","volume":"44","author":"Sun","year":"2009","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"R53-1-20210203","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000293657","article-title":"Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17 and progesterone in postmenopausal women.","volume":"27","author":"Pschera","year":"1989","journal-title":"Gynecol Obstet Invest"},{"key":"R54-1-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJM197801262980406","article-title":"Absorption of estrogens from vaginal creams.","volume":"298","author":"Rigg","year":"1978","journal-title":"N Engl J Med"},{"key":"R55-1-20210203","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cca.2010.01.019","article-title":"Liquid chromatography tandem mass spectrometry assay for fast and sensitive quantification of estrone-sulfate.","volume":"411","author":"Corona","year":"2010","journal-title":"Clin Chim Acta"},{"key":"R56-1-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr960","article-title":"Deficits in plasma oestradiol measurement in studies and management of breast cancer.","volume":"7","author":"Dowsett","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R57-1-20210203","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1055-9965.EPI-07-0028","article-title":"Effect of delays in processing blood samples on measured endogenous plasma sex hormone levels in women.","volume":"16","author":"Jones","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R58-1-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/bcr987","article-title":"The challenge of measuring circulating estradiol at low concentrations.","volume":"7","author":"Toniolo","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R60-1-20210203","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1139\/o78-154","article-title":"Study of the metabolism of 3-propi-ether of estradiol 17 beta estradiol versus 17beta in the perfused rat liver.","volume":"56","author":"Tresca","year":"1978","journal-title":"Can J Biochem"},{"key":"R63-1-20210203","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-5122(96)01072-9","article-title":"Estradiol delivery by vaginal rings: potential for hormone replacement therapy.","volume":"26","author":"Nash","year":"1997","journal-title":"Maturitas"},{"key":"R64-1-20210203","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/92.13.1054","article-title":"Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial.","volume":"92","author":"Ganz","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R65-1-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/cmt.6.1.45.52","article-title":"A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer.","volume":"6","author":"Dew","year":"2003","journal-title":"Climacteric"},{"key":"R66-1-20210203","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"R67-1-20210203","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"R68-1-20210203","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/bcr1378","article-title":"Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.","volume":"8","author":"Rosenberg","year":"2006","journal-title":"Breast Cancer Res"},{"key":"R74-1-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09513590.2012.705389","article-title":"Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy.","volume":"29","author":"Luciano Mariani","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R75-1-20210203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/13697137.2010.522875","article-title":"Recommendations for the management of postmenopausal vaginal atrophy.","volume":"13","author":"Sturdee","year":"2010","journal-title":"Climacteric"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e328365288e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T19:18:47Z","timestamp":1620933527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201311000-00001"}},"subtitle":["is it safe even in cancer patients?"],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328365288e","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}